Co-authored by a former cancer patient and an Associate Chief Oncologist, this A-to-Z reference provides the clear and concise information that cancer patients and their families need.

In an era of promising advances in cancer research, there are considerable and even alarming gaps in the fundamental knowledge and understanding of ovarian cancer. Researchers now know that ovarian cancer is not a single disease-several distinct subtypes exist with different origins, risk factors, genetic mutations, biological behaviors, and prognoses. However, persistent questions have impeded progress toward improving the prevention, early detection, treatment, and management of ovarian cancers. Failure to significantly improve morbidity and mortality during the past several decades is likely due to several factors, including the lack of research being performed by specific disease subtype, lack of definitive knowledge of the cell of origin and disease progression, and incomplete understanding of genetic and non-genetic risk factors. Ovarian Cancers examines the state of the science in ovarian cancer research, identifies key gaps in the evidence base and the challenges to addressing those gaps, considers opportunities for advancing ovarian cancer research, and examines avenues for translation and dissemination of new findings and communication of new information to patients and others. This study makes recommendations for public- and private-sector efforts that could facilitate progress in reducing the incidence of morbidity and mortality from ovarian cancers.

This book is open access under a CC-BY licence. Cancer is perhaps the modern world's most feared disease. Yet, we know relatively little about this malady's history before the nineteenth century. This book provides the first in-depth examination of perceptions of cancerous disease in early modern England. Looking to drama, poetry and polemic as well as medical texts and personal accounts, it contends that early modern people possessed an understanding of cancer which remains recognizable to us today. Many of the ways in which medical practitioners and lay people imagined cancer – as a 'woman's disease' or a 'beast' inside the body – remain strikingly familiar, and they helped to make this disease a byword for treachery and cruelty in discussions of religion, culture and politics. Equally, cancer treatments were among the era's most radical medical and surgical procedures. From buttered frog ointments to agonizing and dangerous surgeries, they raised abiding questions about the nature of disease and the proper role of the medical practitioner.

It has been recognized for almost 200 years that certain families seem to inherit cancer. It is only in the past decade, however, that molecular genetics and epidemiology have combined to define the role of inheritance in cancer more clearly, and to identify some of the genes involved. The causative genes can be tracked through cancer-prone families via genetic linkage and positional cloning. Several of the genes discovered have subsequently been proved to play critical roles in normal growth and development. There are also implications for the families themselves in terms of genetic testing with its attendant dilemmas, if it is not clear that useful action will result. The chapters in The Genetics of Cancer illustrate what has already been achieved and take a critical look at the future directions of this research and its potential clinical applications.

Accelerated partial breast irradiation (APBI) is being rapidly introduced into the clinical management of early breast cancer. APBI, in fact, encompasses a number of different techniques and approaches that include brachytherapy, intraoperative, and external beam techniques. There is currently no single source that describes these techniques and their clinical implementation. This text is a concise handbook designed to assist the clinician in the implementation of APBI. This includes a review of the principles that underlie APBI, a practical and detailed description of each technique for APBI, a review of current clinical results of APBI, and a review of the incidence and management of treatment related complications.

Handbook of Cancer Survivorship Care serves as a practical and concise guide for the multidisciplinary management of cancer survivors. Nearly all of the chapters are authored by a team consisting of a seasoned oncologist and an experienced practitioner who provides direct services in survivorship care. Chapters reflect the importance of interdisciplinary collaboration and cover the high-yield pearls and clinical applications that lead to quality patient care outcomes. Part I discusses the basic concepts of survivorship care, models of care, and clinical tools while addressing late and long-term effects of treatment, screening methods for secondary or recurring tumors, and prevention of disease relapse. Part II includes chapters on cancers commonly seen in community practice, such as breast, prostate, lymphoma, and colorectal. Chapters in Part II provide clinical pearls and disease-specific background, a guide to disease surveillance, instructions for monitoring late effects, early detection tips, and information on psychosocial health, all to better direct clinical assessment and management. With cancer survivors an increasing segment of the healthcare population and survivorship care rapidly evolving, it is paramount that oncologists and other care providers are up-to-date on the clinical strategies, interventions, and recommendations for follow-up care. As a pocket-sized, quick reference, Handbook of Cancer Survivorship Care is an indispensable resource for any healthcare provider – including physicians, nurses, and other practitioners – seeing patients in remission; it covers the must-know points of clinical management and successfully carries over cutting-edge expertise into clinical practice whether it is used at the bedside or in the clinic. Key Features: Includes practical guidance on challenging areas such as addressing psychosocial issues, establishing screening and prevention strategies, managing late effects in cancer survivors and many more Easy-to-read outline format makes referencing in the clinical setting quick and convenient Practical clinical vignettes with self-assessment Q&A accompany chapters in Part II Clinical pearls highlight survivorship guidelines and their application Provides management guidelines and detailed disease surveillance strategies for site-specific cancers Includes digital access to the e-book

In response to a request by the Health Care Financing Administration (HCFA), the Institute of Medicine proposed a study to examine definitions of serious or complex medical conditions and related issues. A seven-member committee was appointed to address these issues. Throughout the course of this study, the committee has been aware of the fact that the topic addressed by this report concerns one of the most critical issues confronting HCFA, health care plans and providers, and patients today. The Medicare+Choice regulations focus on the most vulnerable populations in need of medical care and other services-those with serious or complex medical conditions. Caring for these highly vulnerable populations poses a number of challenges. The committee believes, however, that the current state of clinical and research literature does not adequately address all of the challenges and issues relevant to the identification and care of these patients.

Discusses key principles relative to specific steps in health communications program development, and includes examples of their use. Covers: planning and strategy selection, selecting channels and materials, developing materials and pretesting (pretesting -- what it can and cannot do, pretesting methods, plan and conduct pretests), implementing your program, assessing effectiveness, feedback to refine program and more. Each chapter includes a 3selected readings2 section. Includes: information sources, sample forms, glossary, bibliography, etc. Photos and drawings.

Publisher description: For home, reference and all who need clear explanation of medical terms.